(Q33275386)

English

The effect of the controlled release of basic fibroblast growth factor from ionic gelatin-based hydrogels on angiogenesis in a murine critical limb ischemic model

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

The effect of the controlled release of basic fibroblast growth factor from ionic gelatin-based hydrogels on angiogenesis in a murine critical limb ischemic model (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Hans Layman

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Maria-Grazia Spiga

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Toby Brooks

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Si Pham

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Keith A Webster

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Fotios M Andreopoulos

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

12 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

2646-2654

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Angiogenic effect of intramuscular administration of basic and acidic fibroblast growth factor on skeletal muscles and influence of exercise on muscle angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

21 June 2018

Gelatin as a delivery vehicle for the controlled release of bioactive molecules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

21 June 2018

Management of risk in peripheral artery disease: recent therapeutic advances

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

21 June 2018

Management of peripheral arterial disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

21 June 2018

Beyond angiogenesis: the cardioprotective potential of fibroblast growth factor-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

21 June 2018

Biopolymeric delivery matrices for angiogenic growth factors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

21 June 2018

VEGF gene therapy for coronary artery disease and peripheral vascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

21 June 2018

Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

21 June 2018

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

21 June 2018

Endovascular and surgical revascularization for patients with intermittent claudication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

21 June 2018

Therapeutic angiogenesis in cardiology using protein formulations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

21 June 2018

Protein release from gelatin matrices

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

21 June 2018

Fibroblast growth factor-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

21 June 2018

Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

21 June 2018

Bone regeneration by basic fibroblast growth factor complexed with biodegradable hydrogels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

21 June 2018

Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

21 June 2018

G-CSF-mobilized peripheral blood mononuclear cells from diabetic patients augment neovascularization in ischemic limbs but with impaired capability.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

31 October 2018

Injectable biopolymers enhance angiogenesis after myocardial infarction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

31 October 2018

Controlled release of EGF and bFGF from dextran hydrogels in vitro and in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

31 October 2018

Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

31 October 2018

Denatured collagen as support for a FGF-2 delivery system: physicochemical characterizations and in vitro release kinetics and bioactivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

31 October 2018

Electrospinning of silk fibroin nanofibers and its effect on the adhesion and spreading of normal human keratinocytes and fibroblasts in vitro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

31 October 2018

Gelatin sheet incorporating basic fibroblast growth factor enhances sternal healing after harvesting bilateral internal thoracic arteries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

31 October 2018

Alginate for endovascular treatment of aneurysms and local growth factor delivery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

31 October 2018

Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

31 October 2018

Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

31 October 2018

Molecular Basis of Ligand Recognition by Integrin α5β1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1945227

10 December 2018

Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17320947

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17320947

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous transplantation of granulocyte colony-stimulating factor- mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17320947

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polymeric system for dual growth factor delivery

1 reference

https://pubmed.ncbi.nlm.nih.gov/17320947

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of acute ischemia on ET-1 and its receptors in patients with underlying chronic ischemia of the lower limb

1 reference

https://pubmed.ncbi.nlm.nih.gov/17320947

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.BIOMATERIALS.2007.01.044

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33275386&oldid=1423657565"